* Inogen Inc INGN.OQ reported a quarterly adjusted loss of
$1.14 per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -20
cents. The mean expectation of four analysts for the quarter
was for a loss of 62 cents per share. Wall Street expected
results to range from -71 cents to -57 cents per share.
* Revenue fell 13.8% to $75.90 million from a year ago;
analysts
expected $76.99 million.
* Inogen Inc's reported EPS for the quarter was a loss of
$1.14.
* The company reported a quarterly loss of $26.56 million.
* Inogen Inc shares had risen by 69.0% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Inogen Inc is
$6.50
This summary was machine generated from LSEG data February 28 at
12:07 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.62 -1.14 Missed
Sep. 30 2023 -0.49 -0.55 Missed
Jun. 30 2023 -0.59 -0.42 Beat
Mar. 31 2023 -0.78 -0.88 Missed